6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
ID: 36C77025Q0062Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/03aea37e73c94fd1a943d72bdf6ce551/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.

    Point(s) of Contact
    Kelley CunninghamContracting Officer
    (913) 684-0140
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77025Q0062_1.docx
    The document outlines the solicitation and procurement process for pharmaceutical supplies by the Department of Veterans Affairs (VA) through the National Contracting Office (NCO 15). It includes requirements for vendors to deliver pharmaceuticals to the Consolidated Mail Outpatient Pharmacy (CMOP) in Chelmsford, MA. Key details include the obligation for items to be processed for acceptance, shipping standards via USPS, and electronic payment submission processes. The document stipulates strict guidelines regarding delivery, compliance with the Drug Supply Chain Security Act, and the expectation of providing comprehensive product identification through National Drug Codes (NDCs). Contract terms are governed by various Federal Acquisition Regulation (FAR) clauses ensuring quality provisions, including labeling requirements, acceptance standards, and compliance with regulations concerning recalls and product substitutions. The overall aim is to secure reliable suppliers to maintain pharmaceutical inventory for veterans, ensuring compliance with both federal regulations and VA standards for health care delivery. Vendor bids must encompass a signed SF 1449 form, pricing schedules, and evidence of necessary licensure to participate in this procurement opportunity.
    36C77025Q0062.docx
    The Department of Veterans Affairs is preparing to issue a request for proposals (RFP) for the procurement of seven specific pharmaceuticals to be delivered to the Chelmsford CMOP facility in Massachusetts. The presolicitation notice outlines the products required, including items such as Clomiphene Citrate and Amlodipine/Benzapril combinations, along with their respective quantities and packaging specifications. This RFP is set aside for small businesses under the product service code for drugs and biologicals. Interested vendors must submit their responses by the due date of December 2, 2024, and must comply with the Drug Supply Chain Security Act. Submissions should include a signed solicitation cover page, a price schedule, proof of a valid state wholesale distributor license, and a Trade Agreements Act certificate. All proposals must be directed to the Contracting Officer, Kelley Cunningham, via email. This procurement effort signifies the VA's ongoing commitment to providing necessary pharmaceuticals to support veterans' healthcare needs.
    S02_Pricing Schedule_Q0062.xlsx
    The CMOP Chelmsford Request for Quote (RFQ) 36C77025Q0062 outlines the procurement of pharmaceuticals and medical supplies to be delivered within 10 days of order receipt. Vendors must submit a signed SF1449 solicitation cover page, a completed Excel quote spreadsheet, and proof of a valid State Wholesale Distributor License. Additionally, a Trade Agreements Act Certificate is required. The proposal deadline is set for December 2, 2024, by 3:00 PM Central Time. Each vendor is permitted to submit one quote, indicating any variations in product counts in the vendor comments. Importantly, all products must have a minimum one-year shelf life upon delivery. The document includes detailed line items specifying product descriptions, NDC numbers, manufacturer information, and quantity requirements. The structure emphasizes careful adherence to submission requirements and ensures that vendors are aware of regulatory compliance and quality expectations. This RFQ process highlights the government's effort to procure essential healthcare products efficiently and effectively, ensuring quality and timely delivery to meet national healthcare standards.
    Similar Opportunities
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires compliance with current Good Manufacturing Practices (cGMP) and mandates a unique National Drug Code (NDC) for each product offered, ensuring adherence to FDA regulations and drug supply chain security measures. Interested contractors must submit their proposals by December 31, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov for further information.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    770-25-1-801-0134 -National CMOP ZINC OXIDE OINT
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Zinc Oxide Ointment as part of a contract with the National CMOP Office. Vendors are required to supply varying quantities of this pharmaceutical product, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act and FDA approval. The ointment will be delivered to multiple VA CMOP facilities, with a total requirement exceeding 5,000 units, and must be shipped within 10 days of order receipt. Interested vendors must submit their proposals by December 30, 2024, at 4:00 PM Central Standard Time, including necessary documentation such as a signed SF1449 form and a Buy American Act certificate. For further inquiries, vendors can contact Sarah Fry at sarah.fry2@va.gov or call 913-758-9935.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.